Erratum: Effect of the cumin cyminum L. Intake on weight loss, metabolic profiles and biomarkers of oxidative stress in overweight subjects: A randomized double-blind placebo-controlled clinical trial (Annals of Nutrition and Metabolism (2015) 66:2-3 (117-124) DOI: 10.1159/000373896);Effect of the cumin cyminum L. intake on weight loss, metabolic profiles and biomarkers of oxidative stress in overweight subjects: A randomized double-blind placebo-controlled clinical trial

Annals of Nutrition and Metabolism

Volumn 66, Issue 2-3, 2015, Pages 117-124

  Taghizadeh, Mohsen ^a   Memarzadeh, Mohammad Reza ^b   Asemi, Zatollah ^a   Esmaillzadeh, Ahmad ^c,d  

^a KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Medicinal Plants Research Center of Barij   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

BMI; Cuminum cyminum L.; Insulin metabolism; Lipid concentrations; Overweight

Indexed keywords

BIOLOGICAL MARKER; ESSENTIAL OIL; INSULIN; PLACEBO; TETRAHYDROLIPSTATIN; THYROID HORMONE; GLUTATHIONE; LACTONE;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; CUMIN; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN METABOLISM; MAJOR CLINICAL STUDY; MALE; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WEIGHT REDUCTION; BLOOD; CUMINUM; DIET; IRAN; METABOLOME; MIDDLE AGED; OVERWEIGHT; PHYTOTHERAPY;

CUMINUM CYMINUM;

ADULT; BIOMARKERS; BODY MASS INDEX; CUMINUM; DIET; DOUBLE-BLIND METHOD; FEMALE; GLUTATHIONE; HUMANS; INSULIN; IRAN; LACTONES; MALE; METABOLOME; MIDDLE AGED; OVERWEIGHT; OXIDATIVE STRESS; PHYTOTHERAPY; PLACEBOS; WEIGHT LOSS;

EID: 84924691897     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000529290     Document Type: Erratum

References (29)

1. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - the evidence report. National institutes of health. Obes Res 1998; 6(suppl 2):51S-209S.
2. Shah R, Gayat E, Januzzi JL Jr, Sato N, Cohen-Solal A, diSomma S, Fairman E, Harjola VP, Ishihara S, Lassus J, Maggioni A, Metra M, Mueller C, Mueller T, Parenica J, Pascual-Figal D, Peacock WF, Spinar J, van Kimmenade R, Mebazaa A: Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox. J Am Coll Cardiol 2014; 63: 778-785.
3. Mirzazadeh A, Salimzadeh H, Arabi M, Navadeh S, Hajarizadeh B, Haghdoost AA: Trends of obesity in Iranian adults from 1990s to late 2000s; a systematic review and meta-analysis. Middle East J Dig Dis 2013; 5: 151-157.
4. Lau DC, Douketis JD, Morrison KM, Hramiak IM, Sharma AM, Ur E: 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. CMAJ 2007; 176:S1-S13.
5. Catenacci VA, Hill JO, Wyatt HR: The obesity epidemic. Clin Chest Med 2009; 30: 415-444.
6. Yanovski SZ, Yanovski JA: Long-term drug treatment for obesity: a systematic and clinical review. JAMA 2014; 311: 74-86.
7. Colquitt JL, Picot J, Loveman E, Clegg AJ: Surgery for obesity. Cochrane Database Syst Rev 2009; 2:CD003641.
8. Haslam DW, James WP: Obesity. Lancet 2005; 366: 1197-1209.
9. Kan Y, Kartal M, Ozek T, Aslan S, Baser K: Composition of essential oil of Cuminum cyminum L. according to harvesting times. Turkish J Pharm Sci 2007; 1: 25-29.
10. Dhandapani S, Subramanian VR, Rajagopal S, Namasivayam N: Hypolipidemic effect of Cuminum cyminum L. on alloxan-induced diabetic rats. Pharmacol Res 2002; 46: 251-255.
11. Ahmad M, Akhtar MS, Malik T, Gilani AH: Hypoglycaemic action of the flavonoid fraction of Cuminum nigrum seeds. Phytother Res 2000; 14: 103-106.
12. Mae T, Kishida H, Nishiyama T, Tsukagawa M, Konishi E, Kuroda M, Mimaki Y, Sashida Y, Takahashi K, Kawada T, Nakagawa K, Kitahara M: A licorice ethanolic extract with peroxisome proliferator-activated receptorgamma ligand-binding activity affects diabetes in KK-Ay mice, abdominal obesity in dietinduced obese C57BL mice and hypertension in spontaneously hypertensive rats. J Nutr 2003; 133: 3369-3377.
13. Datau EA, Wardhana, Surachmanto EE, Pandelaki K, Langi JA; Fias: Efficacy of Nigella sativa on serum free testosterone and metabolic disturbances in central obese male. Acta Med Indones 2010; 42: 130-134.
14. Benzie IF, Strain JJ: The ferric reducing ability of plasma (FRAP) as a measure of 'antioxidant power': the FRAP assay. Anal Biochem 1996; 239: 70-76.
15. Beutler E, Gelbart T: Plasma glutathione in health and in patients with malignant disease. J Lab Clin Med 1985; 105: 581-584.
16. Pisprasert V, Ingram KH, Lopez-Davila MF, Munoz AJ, Garvey WT: Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans. Diabetes Care 2013; 36: 845-853.
17. Badary OA: Thymoquinone attenuates ifosfamide-induced Fanconi syndrome in rats and enhances its antitumor activity in mice. J Ethnopharmacol 1999; 67: 135-142.
18. Hamilton-Fairley D, Kiddy D, Anyaoku V, Koistinen R, Seppala M, Franks S: Response of sex hormone binding globulin and insulinlike growth factor binding protein-1 to an oral glucose tolerance test in obese women with polycystic ovary syndrome before and after calorie restriction. Clin Endocrinol (Oxf) 1993; 39: 363-367.
19. Kiddy DS, Hamilton-Fairley D, Seppala M, Koistinen R, James VH, Reed MJ, Franks S: Diet-induced changes in sex hormone binding globulin and free testosterone in women with normal or polycystic ovaries: correlation with serum insulin and insulin-like growth factor-I. Clin Endocrinol (Oxf) 1989; 31: 757-763.
20. Moran LJ, Noakes M, Clifton PM, Tomlinson L, Galletly C, Norman RJ: Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003; 88: 812-819.
21. Sacks FM, Campos H: Polyunsaturated fatty acids, inflammation, and cardiovascular disease: time to widen our view of the mechanisms. J Clin Endocrinol Metab 2006; 91: 398-400.
22. Talpur N, Echard B, Ingram C, Bagchi D, Preuss H: Effects of a novel formulation of essential oils on glucose-insulin metabolism in diabetic and hypertensive rats: a pilot study. Diabetes Obes Metab 2005; 7: 193-199.
23. Badr G, Mahmoud MH, Farhat K, Waly H, Al-Abdin OZ, Rabah DM: Maternal supplementation of diabetic mice with thymoquinone protects their offspring from abnormal obesity and diabetes by modulating their lipid profile and free radical production and restoring lymphocyte proliferation via PI3K/AKT signaling. Lipids Health Dis 2013; 12: 37.
24. Frayn KN: Insulin resistance, impaired postprandial lipid metabolism and abdominal obesity. A deadly triad. Med Princ Pract 2002; 11(suppl 2):31-40.
25. El-Dakhakhny M, Mady N, Lembert N, Ammon HP: The hypoglycemic effect of Nigella sativa oil is mediated by extrapancreatic actions. Planta Med 2002; 68: 465-466.
26. Samani KG, Farrokhi E: Effects of cumin extract on oxLDL, paraoxanase 1 activity, FBS, total cholesterol, triglycerides, HDL-C, LDLC, Apo A1, and Apo B in in the patients with hypercholesterolemia. Int J Health Sci (Qassim) 2014; 8: 39-43.
27. Gupta RS, Saxena P, Gupta R, Kachhawa JB: Evaluation of reversible contraceptive activities of Cuminum cyminum in male albino rats. Contraception 2011; 84: 98-107.
28. Shirke SS, Jagtap AG: Effects of methanolic extract of Cuminum cyminum on total serum cholesterol in ovariectomized rats. Indian J Pharmacol 2009; 41: 92-93.
29. Amin KA, Nagy MA: Effect of Carnitine and herbal mixture extract on obesity induced by high fat diet in rats. Diabetol Metab Syndr 2009; 1: 17.